Hers vs TMates: Wegovy vs Compounded Semaglutide Options

Hers vs TMates is a choice between FDA-approved brand-name GLP-1s and a flat-rate compounded semaglutide program. Early verdict: choose Hers if you want brand-name Wegovy® and no compounded medications; choose TMates if you prioritize a flat $199/month price with 24/7 U.S. doctor access.

Key differences at a glance: price, medication type, and access

Direct comparison shows three decisive distinctions: Hers markets FDA-approved Wegovy® (brand-name semaglutide) with pricing starting at $149/mo and membership requirements, while TMates offers clinically dosed compounded semaglutide at a flat $199/month with no step-up fees. TMates highlights 24/7 access to U.S.-based doctors and coverage in all 50 states; Hers notes availability is not in all 50 states and requires an active membership for medication.

Medication type and regulatory notes

Hers provides FDA-approved Wegovy®, explicitly stating it is not a compounded product. TMates supplies compounded semaglutide formulated in U.S. facilities and notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both providers reference the regulatory distinction between FDA-approved brand-name products and compounded alternatives.

Why this matters

The source for Hers emphasizes FDA-approved brand-name GLP-1s, no compounded medications, and that compounded medications are not FDA-reviewed. TMates stresses that its compounded semaglutide uses the same active ingredient as Ozempic and Wegovy but is compounded and therefore not an FDA-approved finished product.

Price structure and membership

Pricing is a core contrast. Hers lists Wegovy® pill from $149/mo and injectables from $199/mo, and clarifies an active Hers Weight Loss Membership is required ($39 first month, auto-renews at $149/month thereafter) with membership and medication billed separately. TMates offers a flat $199/month at every dose with no step-up fees as dosage escalates and lists various multi-month tiers in captured landing-page evidence.

Clinical support and access

TMates promotes 24/7 access to U.S.-based doctors and licensed coverage in all 50 states, with virtual check-ins and physician availability beyond messaging-only support. Hers describes a personalized care team with ongoing dose check-ins but notes treatment is available only when a licensed clinician determines it is medically appropriate and that availability is not in all 50 states.

Explore TMates’ 24/7 doctor access

Dosing flexibility, brands, and availability

Hers offers FDA-approved Wegovy® and references brand options like Wegovy® and Zepbound® as FDA-approved for weight loss, while acknowledging Ozempic® is FDA-approved for type 2 diabetes and may be prescribed off-label at a clinician’s discretion. TMates positions compounded semaglutide as offering more flexibility in dosage and access at a lower price point relative to brand-name options, and states it ships to most states with availability based on medical eligibility.

Supported comparison table

View TMates’ flat-rate semaglutide program

Patient experience and program notes

Hers emphasizes name-brand medication with no price markups and a personalized care team. It also states medication is not available without an active membership and that a prescription is not guaranteed. TMates highlights a dependable full-service model, consistent physician availability, free shipping, and that compounded semaglutide gives more dosage flexibility.

Conclusion: choosing between Hers and TMates

Hers vs TMates presents a clear tradeoff: Hers for FDA-approved Wegovy® and avoidance of compounded medications; TMates for a predictable flat $199/month compounded semaglutide plan with 24/7 U.S. doctor access and broader stated state coverage.

Choose Hers if you want FDA-approved Wegovy® brand-name semaglutide, prefer not to use compounded medications, and accept membership requirements and state-based availability limitations.

Choose TMates if you prefer a flat $199/month price at every dose, need 24/7 access to U.S.-based doctors, and are comfortable with compounded semaglutide formulated in U.S. facilities.